SRTSF yields 2.26% · PFE yields 6.20%● Live data
📍 SRTSF pulled ahead of the other in Year 1
Combined, SRTSF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SRTSF + PFE for your $10,000?
Gr. Sarantis S.A., together with its subsidiaries, produces and trades in cosmetics, household products, and parapharmaceutical products. It operates through four segments: Mass Market Cosmetics, Household Products, Other Sales, and Private Label Products. The company provides personal care products, including baby care, baby wash, grooming, hair care, hair colorant, hair styling, hand wash, oral care, personal hygiene, shaving, skin care, and sun care products, as well as deodorants and fragrances; and home care products, such as dishwashing, drainer care, food packaging, insect control, and shoe care products, as well as bathroom cleaners, cleaning tools, septic tank activators, and garbage bags. It also offers health care products comprising food supplements, health and self-care products, and skin and sun care products; cosmetics, including candle, make up, treatment, and home and other fragrance products; and professional products, such as cleaning tools, detergents, and food and other packaging products. The company offers its products through hypermarkets, supermarkets, groceries, beauty shops, and pharmacies. It operates in Greece, Poland, Romania, Bulgaria, Serbia, the Czech Republic, Slovakia, Hungary, North Macedonia, Bosnia, Portugal, Ukraine, Russia, Cyprus, and France, as well as exports its products to approximately 50 countries in Europe, Asia, Africa, and Oceania. The company was founded in 1930 and is headquartered in Athens, Greece.
Full SRTSF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.